vs
Side-by-side financial comparison of Elanco Animal Health Inc (ELAN) and SERVICE CORP INTERNATIONAL (SCI). Click either name above to swap in a different company.
Elanco Animal Health Inc is the larger business by last-quarter revenue ($1.1B vs $1.1B, roughly 1.0× SERVICE CORP INTERNATIONAL). SERVICE CORP INTERNATIONAL runs the higher net margin — 14.3% vs -24.1%, a 38.5% gap on every dollar of revenue. On growth, Elanco Animal Health Inc posted the faster year-over-year revenue change (12.2% vs 1.7%). SERVICE CORP INTERNATIONAL produced more free cash flow last quarter ($87.2M vs $46.0M). Over the past eight quarters, SERVICE CORP INTERNATIONAL's revenue compounded faster (3.1% CAGR vs -2.6%).
Elanco Animal Health Incorporated is an American pharmaceutical company which produces medicines and vaccinations for pets and livestock. Until 2019, the company was a subsidiary of Eli Lilly and Company, before being divested. It is the third-largest animal health company in the world.
International Distribution Services Limited is a British company providing postal and courier services. IDS was created in 2013 by the UK government as a new holding company of Royal Mail, and a majority of its shares were then sold on the London Stock Exchange, with the government initially retaining a 30 per cent at the time. As of April 2025, IDS is owned and operated by Czech-based EP Group, owned by Daniel Křetínský.
ELAN vs SCI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.1B | $1.1B |
| Net Profit | $-276.0M | $159.4M |
| Gross Margin | 51.5% | 28.0% |
| Operating Margin | -22.6% | 24.8% |
| Net Margin | -24.1% | 14.3% |
| Revenue YoY | 12.2% | 1.7% |
| Net Profit YoY | -3350.0% | 5.3% |
| EPS (diluted) | $-0.55 | $1.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.1B | $1.1B | ||
| Q3 25 | $1.1B | $1.1B | ||
| Q2 25 | $1.2B | $1.1B | ||
| Q1 25 | $1.2B | $1.1B | ||
| Q4 24 | $1.0B | $1.1B | ||
| Q3 24 | $1.0B | $1.0B | ||
| Q2 24 | $1.2B | $1.0B | ||
| Q1 24 | $1.2B | $1.0B |
| Q4 25 | $-276.0M | $159.4M | ||
| Q3 25 | $-34.0M | $117.5M | ||
| Q2 25 | $11.0M | $122.9M | ||
| Q1 25 | $67.0M | $142.9M | ||
| Q4 24 | $-8.0M | $151.4M | ||
| Q3 24 | $364.0M | $117.8M | ||
| Q2 24 | $-50.0M | $118.2M | ||
| Q1 24 | $32.0M | $131.3M |
| Q4 25 | 51.5% | 28.0% | ||
| Q3 25 | 53.4% | 25.1% | ||
| Q2 25 | 57.5% | 25.5% | ||
| Q1 25 | 57.3% | 27.1% | ||
| Q4 24 | 50.9% | 28.0% | ||
| Q3 24 | 52.2% | 24.9% | ||
| Q2 24 | 58.2% | 24.9% | ||
| Q1 24 | 57.3% | 26.2% |
| Q4 25 | -22.6% | 24.8% | ||
| Q3 25 | -4.4% | 21.4% | ||
| Q2 25 | 2.0% | 21.1% | ||
| Q1 25 | 5.0% | 23.4% | ||
| Q4 24 | -5.0% | 24.0% | ||
| Q3 24 | 54.3% | 20.9% | ||
| Q2 24 | -2.7% | 21.4% | ||
| Q1 24 | 1.0% | 22.2% |
| Q4 25 | -24.1% | 14.3% | ||
| Q3 25 | -3.0% | 11.1% | ||
| Q2 25 | 0.9% | 11.5% | ||
| Q1 25 | 5.6% | 13.3% | ||
| Q4 24 | -0.8% | 13.8% | ||
| Q3 24 | 35.3% | 11.6% | ||
| Q2 24 | -4.2% | 11.4% | ||
| Q1 24 | 2.7% | 12.6% |
| Q4 25 | $-0.55 | $1.13 | ||
| Q3 25 | $-0.07 | $0.83 | ||
| Q2 25 | $0.02 | $0.86 | ||
| Q1 25 | $0.13 | $0.98 | ||
| Q4 24 | $-0.01 | $1.02 | ||
| Q3 24 | $0.73 | $0.81 | ||
| Q2 24 | $-0.10 | $0.81 | ||
| Q1 24 | $0.06 | $0.89 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $545.0M | $243.6M |
| Total DebtLower is stronger | $3.9B | $5.1B |
| Stockholders' EquityBook value | $6.5B | $1.6B |
| Total Assets | $13.4B | $18.7B |
| Debt / EquityLower = less leverage | 0.60× | 3.10× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $545.0M | $243.6M | ||
| Q3 25 | $505.0M | $241.3M | ||
| Q2 25 | $539.0M | $255.4M | ||
| Q1 25 | $487.0M | $227.2M | ||
| Q4 24 | $468.0M | $218.8M | ||
| Q3 24 | $490.0M | $185.4M | ||
| Q2 24 | $416.0M | $184.4M | ||
| Q1 24 | $345.0M | $205.6M |
| Q4 25 | $3.9B | $5.1B | ||
| Q3 25 | $4.0B | $5.0B | ||
| Q2 25 | $4.1B | $5.0B | ||
| Q1 25 | $4.4B | $4.7B | ||
| Q4 24 | $4.3B | $4.8B | ||
| Q3 24 | $4.4B | $4.7B | ||
| Q2 24 | $5.7B | $4.7B | ||
| Q1 24 | $5.8B | $4.6B |
| Q4 25 | $6.5B | $1.6B | ||
| Q3 25 | $6.7B | $1.6B | ||
| Q2 25 | $6.8B | $1.6B | ||
| Q1 25 | $6.4B | $1.7B | ||
| Q4 24 | $6.1B | $1.7B | ||
| Q3 24 | $6.5B | $1.6B | ||
| Q2 24 | $5.9B | $1.5B | ||
| Q1 24 | $6.1B | $1.6B |
| Q4 25 | $13.4B | $18.7B | ||
| Q3 25 | $13.6B | $18.4B | ||
| Q2 25 | $13.7B | $18.0B | ||
| Q1 25 | $12.9B | $17.3B | ||
| Q4 24 | $12.6B | $17.4B | ||
| Q3 24 | $13.3B | $17.4B | ||
| Q2 24 | $13.8B | $16.8B | ||
| Q1 24 | $14.0B | $16.7B |
| Q4 25 | 0.60× | 3.10× | ||
| Q3 25 | 0.59× | 3.17× | ||
| Q2 25 | 0.61× | 3.19× | ||
| Q1 25 | 0.69× | 2.87× | ||
| Q4 24 | 0.70× | 2.83× | ||
| Q3 24 | 0.67× | 2.92× | ||
| Q2 24 | 0.96× | 3.05× | ||
| Q1 24 | 0.95× | 2.90× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $108.0M | $212.9M |
| Free Cash FlowOCF − Capex | $46.0M | $87.2M |
| FCF MarginFCF / Revenue | 4.0% | 7.8% |
| Capex IntensityCapex / Revenue | 5.4% | 11.3% |
| Cash ConversionOCF / Net Profit | — | 1.34× |
| TTM Free Cash FlowTrailing 4 quarters | $284.0M | $554.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $108.0M | $212.9M | ||
| Q3 25 | $219.0M | $252.3M | ||
| Q2 25 | $237.0M | $166.4M | ||
| Q1 25 | $-4.0M | $311.1M | ||
| Q4 24 | $177.0M | $264.1M | ||
| Q3 24 | $162.0M | $263.8M | ||
| Q2 24 | $200.0M | $196.9M | ||
| Q1 24 | $2.0M | $220.1M |
| Q4 25 | $46.0M | $87.2M | ||
| Q3 25 | $127.0M | $150.7M | ||
| Q2 25 | $180.0M | $83.4M | ||
| Q1 25 | $-69.0M | $233.0M | ||
| Q4 24 | $130.0M | $151.8M | ||
| Q3 24 | $120.0M | $162.8M | ||
| Q2 24 | $166.0M | $100.8M | ||
| Q1 24 | $-22.0M | $140.3M |
| Q4 25 | 4.0% | 7.8% | ||
| Q3 25 | 11.2% | 14.2% | ||
| Q2 25 | 14.5% | 7.8% | ||
| Q1 25 | -5.8% | 21.7% | ||
| Q4 24 | 12.7% | 13.9% | ||
| Q3 24 | 11.7% | 16.1% | ||
| Q2 24 | 14.0% | 9.7% | ||
| Q1 24 | -1.8% | 13.4% |
| Q4 25 | 5.4% | 11.3% | ||
| Q3 25 | 8.1% | 9.6% | ||
| Q2 25 | 4.6% | 7.8% | ||
| Q1 25 | 5.4% | 7.3% | ||
| Q4 24 | 4.6% | 10.3% | ||
| Q3 24 | 4.1% | 10.0% | ||
| Q2 24 | 2.9% | 9.3% | ||
| Q1 24 | 2.0% | 7.6% |
| Q4 25 | — | 1.34× | ||
| Q3 25 | — | 2.15× | ||
| Q2 25 | 21.55× | 1.35× | ||
| Q1 25 | -0.06× | 2.18× | ||
| Q4 24 | — | 1.75× | ||
| Q3 24 | 0.45× | 2.24× | ||
| Q2 24 | — | 1.67× | ||
| Q1 24 | 0.06× | 1.68× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ELAN
| Pet Health | $489.0M | 43% |
| Cattle | $296.0M | 26% |
| Poultry | $237.0M | 21% |
| Swine | $107.0M | 9% |
| Contract Manufacturing | $15.0M | 1% |
SCI
| Cemetery | $510.9M | 46% |
| Funeral Matured Preneed Revenue | $196.5M | 18% |
| Cemetery Recognized Preneed Merchandise And Service Revenue | $107.4M | 10% |
| Cemetery Atneed Revenue | $104.9M | 9% |
| CA | $56.4M | 5% |
| Funeral Other Revenue | $54.6M | 5% |
| Cemetery Other Revenue | $40.2M | 4% |
| Nonfuneral Home Revenue | $28.1M | 3% |
| Non Funeral Home Preneed Sales Revenue | $22.0M | 2% |
